Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel
暂无分享,去创建一个
Catalin C. Barbacioru | C. Barbacioru | M. Fakih | S. Kopetz | Kyoung-Mee Kim | Jeeyun Lee | J. Odegaard | J. Willis | Marcin Sikora | Hyuk Lee | R. Eskander | N. Peled | T. Yoshino | S. Fairclough | P. Kasi | S. Kim | M. Benavides | M. Lefterova | R. Lanman | K. Banks | Alexander Artyomenko | V. Raymond | M. Cusnir | Jinchul Kim | Stephen R. Fairclough | Darya I Chudova | D. Catenacci | Amirali Talasaz | K. Mody | G. Azzi | Timmy Nguyen | Y. Nakamura | J. Zhao | Danielle Gavino | Darya I. Chudova
[1] V. Papadimitrakopoulou,et al. Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer , 2019, Clinical Cancer Research.
[2] A. Duval,et al. Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status , 2019, JAMA oncology.
[3] P. Keegan,et al. FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors , 2019, Clinical Cancer Research.
[4] Ahmet Zehir,et al. Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Sharyn I. Katz,et al. Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non–Small Cell Lung Cancer , 2019, JAMA oncology.
[6] Kathleen R. Cho,et al. Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.
[7] Joon-Oh Park,et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer , 2018, Nature Medicine.
[8] A. Bardelli,et al. Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer. , 2018, Cancer cell.
[9] David R. Riley,et al. Abstract 1286: Analytical validation of an integrated next-generation sequencing pan-cancer liquid biopsy approach for detection of microsatellite instability , 2018, Bioinformatics and Systems Biology.
[10] J. Lindberg,et al. Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis , 2018, bioRxiv.
[11] C. Paweletz,et al. Validation of a Plasma-Based Comprehensive Cancer Genotyping Assay Utilizing Orthogonal Tissue- and Plasma-Based Methodologies , 2018, Clinical Cancer Research.
[12] J. Marshall,et al. Microsatellite instability status determined by next‐generation sequencing and compared with PD‐L1 and tumor mutational burden in 11,348 patients , 2018, Cancer medicine.
[13] Kathleen R. Cho,et al. Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.
[14] S. Mortimer,et al. The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients , 2017, Clinical Cancer Research.
[15] M. Hall,et al. Mismatch Repair Deficiency Testing in Patients With Colorectal Cancer and Nonadherence to Testing Guidelines in Young Adults , 2017, JAMA oncology.
[16] Russell Bonneville,et al. Landscape of Microsatellite Instability Across 39 Cancer Types. , 2017, JCO precision oncology.
[17] G. Oxnard,et al. Application of Plasma Genotyping Technologies in Non–Small Cell Lung Cancer: A Practical Review , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[18] E. Nakakura,et al. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.
[19] Ludmila V. Danilova,et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade , 2017, Science.
[20] R. Lothe,et al. Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies , 2017, Molecular Cancer.
[21] Zachary J. Heins,et al. Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making. , 2017, JCO precision oncology.
[22] Gad Getz,et al. Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma. , 2017, Cancer discovery.
[23] Mingming Jia,et al. COSMIC: somatic cancer genetics at high-resolution , 2016, Nucleic Acids Res..
[24] Jay Shendure,et al. Classification and characterization of microsatellite instability across 18 cancer types , 2016, Nature Medicine.
[25] Anil Vachani,et al. Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA , 2016, Clinical Cancer Research.
[26] James Ziai,et al. Mismatch repair deficiency testing in clinical practice , 2016, Expert review of molecular diagnostics.
[27] James R. Eshleman,et al. Microsatellite Instability as a Biomarker for PD-1 Blockade , 2016, Clinical Cancer Research.
[28] B. Kermani,et al. Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA , 2015, PloS one.
[29] Bert Vogelstein,et al. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. , 2015, The New England journal of medicine.
[30] B. Vogelstein,et al. PD-1 blockade in tumors with mismatch repair deficiency. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] Quan P. Ly,et al. Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.
[32] Colin C Pritchard,et al. Microsatellite instability detection by next generation sequencing. , 2014, Clinical chemistry.
[33] James D. Murphy,et al. Colon cancer, version 3.2014. , 2014, Journal of the National Comprehensive Cancer Network : JNCCN.
[34] O. Griffith,et al. COSMIC (Catalogue of Somatic Mutations in Cancer) , 2014 .
[35] Yuheng Lu,et al. A Novel Approach for Characterizing Microsatellite Instability in Cancer Cells , 2013, PloS one.
[36] Quan P. Ly,et al. Esophageal and esophagogastric junction cancers. , 2011, Journal of the National Comprehensive Cancer Network : JNCCN.
[37] W. Frankel,et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). , 2005, The New England journal of medicine.
[38] Sudhir Srivastava,et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.
[39] Daniel J Sargent,et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] S Srivastava,et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.
[41] Matthew P. Goetz,et al. NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY , 2019 .
[42] Andrew Dunford,et al. Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma. , 2018, Cancer discovery.
[43] M. Millenson,et al. Cancer-Associated Venous Thromboembolic Disease , Version 2 . 2018 Featured Updates to the NCCN Guidelines , 2018 .
[44] A. Bronkhorst,et al. Characterization of the cell-free DNA released by cultured cancer cells. , 2016, Biochimica et biophysica acta.
[45] Quan P. Ly,et al. Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.
[46] H. Akaike,et al. Information Theory and an Extension of the Maximum Likelihood Principle , 1973 .
[47] E CARBONETTO,et al. [Colon Cancer]. , 1958, El Dia medico.